logo

For the Inventor, By the Inventor

Villejuif, France

Institut Gustave Roussy


USPTO Granted Patents = 96



Trademarks = 3

Forward Citations = 481

Loading Chart...
Loading Chart...

216 inventors (with patents filed for the assignee):

goldMedal Laurence Zitvogel (19 out of 20 patents)

silverMedal William Vainchenker (11 out of 13 patents)

bronzeMedal Guido Kroemer (8 out of 16 patents)

4.  Thierry Heidmann (8 out of 11 patents)

5.  Eric Deutsch (7 out of 8 patents)

6.  Nicole Casadevall (6 out of 7 patents)

7.  Frederic Triebel (6 out of 25 patents)

8.  Jean-Pierre Le Couedic (5 out of 6 patents)

9.  Didier Desmaele (5 out of 9 patents)

10.  Thierry Hercend (5 out of 17 patents)

11.  Mouad Alami (4 out of 11 patents)

12.  Franck Viguie (4 out of 4 patents)

13.  Olivier Bernard (4 out of 8 patents)

14.  Michaela Fontenay (4 out of 6 patents)

15.  Francois Delhommeau (4 out of 4 patents)


Core Competencies:
Water-In-Oil Emulsions
Tubulin Polymerisation Inhibitors
Colorectal Cancer Treatments
Microbiota Composition
Immunogenic Sequences
Cytokine Treatments
Oncolytic Virus Therapy
JAK2 Mutation Diagnostics
Cancer Prognostic Markers
HIV-1 Treatment Methods
Natural Killer Cell Dysfunction
Oxazaphosphorine Derivatives

96 patents:

1. 12511747 - Method for training a decision system for segmenting medical images (2025-12-30),
2. 12458594 - Injectable water-in-oil emulsions and uses thereof (2025-11-04),
3. 12371417 - Compounds with tubulin polymerisation inhibitory activity and immunomodulatory properties (2025-07-29),
4. 12246044 - Bacterial and cell compositions for the treatment of colorectal cancer and methods for assessing a prognosis for patients having the same (2025-03-11),
5. 12213978 - Madrasin-derivative compounds, composition and uses thereof for treating cancer (2025-02-04),
6. 12144839 - Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 antibodies and use of microbial modulators for improving the efficacy of an anti-PD1/PD-L1/PD-L2 AB-based treatment (2024-11-19),
7. 12102672 - Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer (2024-10-01),
8. 11957868 - Means for transporting persons with reduced mobility comprising a device with for connecting to aserum holder, associated connecting assembly (2024-04-16),
9. 11732303 - Prognostic marker for myeloproliferative neoplasms (2023-08-22),
10. 11730732 - Oral suspension of temozolomide (2023-08-22),
11. 11684640 - Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 antibodies and use of microbial modulators for improving the efficacy of an anti-PD1/PD-L1/PD-L2 ab-based (2023-06-27),
12. 11634405 - Compounds with tubulin polymerisation inhibitory activity and immunomodulatory properties (2023-04-25),
13. 11603568 - NOX2 as a biomarker of radiotherapy efficiency in cancer patients (2023-03-14),
14. 11517575 - Use of minaprine to reduce tumor growth (2022-12-06),
15. 11471463 - Enhancers of cellular cannibalism for use to sensitize tumors to radiation therapy (2022-10-18),
Institut Gustave Roussy is a leading comprehensive cancer center in Europe, dedicated to patient care, research, and education. With an expert multidisciplinary team and state-of-the-art facilities, Institut Gustave Roussy aims to provide the best cancer care and improve patient outcomes through innovative research and cutting-edge treatments.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

...
96 Patents

#1 in Villejuif

#276 in France

#7,849 in the World

...
Villejuif, France

Institut Gustave Roussy

Forward Citations = 481

216 inventors:

goldMedal Laurence Zitvogel (19 out of 20 patents)

silverMedal William Vainchenker (11 out of 13 patents)

bronzeMedal Guido Kroemer (8 out of 16 patents)

4.  Thierry Heidmann (8 out of 11 patents)

5.  Eric Deutsch (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com
Loading…